Psychiatry

Lindsay N. Oberman reviews evidence for transcranial magnetic stimulation protocols in autism spectrum disorder. The seminar first explains how TMS works and how it can probe the brain mechanisms associated with autism. It then presents NIH research using repetitive TMS as an experimental therapeutic tool, examining its effects on both brain function and behaviour to guide the development of potential interventions. Online via Duke Zoom. Wednesday 7 October 2026, 16:00 EDT (America/New_York; UTC−4). Register through the event-specific Register Here link on the Duke Autism Seminar Series page to receive remote access. The presentation will not be recorded. Accommodation requests should reach the organizer at least ten days before the event. The speaker directs NIMH’s Developmental Clinical Neurophysiology and Neurostimulation Research Program.

The European College of Neuropsychopharmacology connects fundamental brain research with psychiatric and neurological treatment through keynote and plenary lectures, scientific symposia, educational updates, discussions and posters. The programme examines how mechanisms at molecular, circuit and social levels can inform interventions for brain disorders. Kay M. Tye (Salk Institute) addresses neural regulation of social homeostasis. Ian Maze (Icahn School of Medicine at Mount Sinai) examines protein monoaminylation in development, plasticity and disease. Oliver Howes (King’s College London) considers routes to new psychiatric medicines using schizophrenia research. Frank Winkler (University of Heidelberg and German Cancer Research Centre) discusses malignant brain networks. Julia Sacher (Max Planck Institute and Leipzig University) examines hormonal transitions and women’s brain health using longitudinal and multimodal imaging. Lukoye Atwoli (Aga Khan University) connects social context with mental-health biology, while Lucia Valmaggia (University of Melbourne) examines virtual reality for youth mental-health assessment and treatment. Organized by the European College of Neuropsychopharmacology through Stichting 39th ECNP Congress. Hybrid, 10–13 October 2026, at ICM – International Congress Center Messe München, Am Messesee 6, 81829 Munich, Germany. All programme times are Europe/Berlin, CEST (UTC+02:00). On 10 October, the exhibition opens at 11:00, industry sessions at 11:15, posters at 12:00, and the welcome/keynote runs 15:00–16:20. Sessions on 11–13 October start at 08:40; the final closing session on 13 October ends at 15:00. Consult the official schedule for individual sessions. Register through the official congress registration page; a MyECNP account is required. In-person tickets include physical attendance and online access. Virtual tickets provide selected livestreamed sessions and on-demand congress content until 11 January 2027 at 12:00 CET. Regular standard in-person fees through 9 October are EUR 825 for members and EUR 1,045 for nonmembers, plus 19% VAT. Regular virtual fees are EUR 455 and EUR 580 respectively, plus applicable VAT. Reduced rates are available for eligible early-career scientists and residents of countries with developing economies; consult the official fee table for criteria and other categories. Residents of the Russian Federation are eligible only for virtual registration. Registration closes 13 October 2026 at 13:00 CEST.

Matthew J. Girgenti discusses how research on individual brain cells and the three-dimensional organization of DNA is changing the biological understanding of post-traumatic stress disorder. The seminar examines how these approaches reveal trauma-associated brain changes and identify possible targets for more effective, personalized treatments. Girgenti is a neuroscientist in Yale School of Medicine’s Department of Psychiatry. Jeffrey Borenstein moderates this Meet the Scientist session. Online via the BBRF Zoom webinar. Tuesday 13 October 2026, 14:00 EDT (America/New_York; UTC−4). Follow Register Today on the organizer’s event page to the event-specific Zoom form. Advance registration is available to researchers, students, healthcare providers, mental-health organizations, patients and family members.

Ta-Wei Guu examines whether continuous data from wearable devices can reveal aspects of older adults’ depression and dementia that conventional clinical assessments miss. The session covers behavioural patterns, sleep disruption and treatment responses measured outside clinical settings, and considers how repeated observations can track changes in health over time. Guu also presents plans for a technology-enabled longitudinal cohort to study ageing populations over months and years, discussing how the resulting patterns could inform research and clinical practice. The session includes questions and discussion. Guu is an assistant professor and consultant psychiatrist at CMUBH in Taiwan, with an affiliation to King’s College London. Online via Dementia Researcher Communities livestream. Wednesday 21 October 2026, 12:00–12:45 BST (Europe/London; UTC+1). This free event requires a Dementia Researcher Communities account: open the event page, sign in or create an account, and RSVP to access the livestream. Organized by Dementia Researcher, delivered by University College London.

Fund neuroimaging research into the mechanisms of mental and behavioural health disorders, with the aim of improving interventions and outcomes. Relevant conditions include mood and anxiety disorders, autism, ADHD, schizophrenia, chronic pain and substance-use disorders. Up to USD 250,000 supports two years of direct research costs, including justified salary and imaging expenses. Applicants need ASNR membership and the specified radiology credentials or appointment. Submit by 30 October 2026 at 9 a.m. Central Time.

UKRI invites interdisciplinary teams to investigate gambling-related harm and develop evidence for prevention and treatment. The call spans research-council disciplines and expects participation from people with lived or learned experience of gambling harms. Projects may run for up to three years, with full economic costs up to £2 million; UKRI normally covers 80% of those costs. This project-cost ceiling is distinct from the funder contribution. The programme has an £18 million budget. Applications opened on 21 September 2026 and close at 16:00 UK time on 8 December 2026.

Fund neuroimaging research into the mechanisms of mental and behavioural health disorders, with the aim of improving interventions and outcomes. Relevant conditions include mood and anxiety disorders, autism, ADHD, schizophrenia, chronic pain and substance-use disorders. Up to USD 250,000 supports two years of direct research costs, including justified salary and imaging expenses. Applicants need ASNR membership and the specified radiology credentials or appointment. Submit by 30 October 2026 at 9 a.m. Central Time.

Jason Lerch presents a translational neuroimaging analysis spanning mouse models and human MRI cohorts to identify biologically informed subgroups across autism and related neurodevelopmental conditions.

John N. Constantino and Jeffrey Borenstein examine how individualized education planning can support children with developmental, behavioral and mental-health challenges. Educators and counselors often recognize difficulties early, and the extensive time children spend at school offers a major opportunity to support maturation alongside clinical care. The discussion explores the complexities of individualized education plans and how educators and clinicians can apply precision-medicine approaches to tailor them to each child, making everyday school experiences more effective for development and adaptation.

UKRI invites interdisciplinary teams to investigate gambling-related harm and develop evidence for prevention and treatment. The call spans research-council disciplines and expects participation from people with lived or learned experience of gambling harms. Projects may run for up to three years, with full economic costs up to £2 million; UKRI normally covers 80% of those costs. This project-cost ceiling is distinct from the funder contribution. The programme has an £18 million budget. Applications opened on 21 September 2026 and close at 16:00 UK time on 8 December 2026.